The Drugs for Neglected Diseases initiative (DNDi) is an independent, non-profit partnership working to research and develop new and improved treatments for neglected diseases such as visceral leishmaniasis also known as kala azar (cutaneous and muco-cutaneous forms), sleeping sickness (human African trypanosomiasis), Chagas disease and malaria.

The initiative was founded in 2003 by the Brazilian Oswaldo Cruz Foundation/Farmanguinhos, the Indian Council for Medical Research, the Kenya Medical Research Institute, the Ministry of Health of Malaysia, the Pasteur Institute in France, and MSF. The World Health Organization’s Special Programme for Research and Training in Tropical Diseases is a permanent observer.

MSF is part of the scientific advisory group and has seats on the board.

To learn more, please visit www.dndi.org

Press release
MSF announces CMV retinitis patients receiving new treatment
Medical publications
Hypokalaemia-Induced Rhabdomyolysis after Treatment of PKDL with High-Dose AmBisome in Bangladesh—A...
Interview with Dr Unni Karunakara, international President of Médecins Sans Frontières (MSF) on why...
A letter by Dr Manica Balesagaram on DNDI's successes and challenges for the future.
Briefing paper
Press release
Despite important progress in R...
Press release
Advances in the development of new diagnostic tests and treatment bode well for the fight against...
Institutional information
Drugs for Neglected Diseases initiative (DNDi) and Epicentre
“There are millions of children with HIV/AIDS in low- and middle-income countries, but their needs...
Treating DR-TB is complicated from a programmatic perspective: treatment is individualised,...
The resolution, 'Chagas Disease: Control and Elimination', to be adopted by the World Health...
Press release
A new treatment option against sleeping sickness, a fatal disease which threatens 60 million people...
Press release
Greater governmental leadership is needed to foster medical innovation for millions suffering from...
Press release
Toxic treatments with older drugs should be phased out.
Press release
First medicines developed by Drugs for Neglected Diseases Initiative (DNDi) will be easier to use...
Press release
"We cannot accept that we must practice second-class medicine just because our patients live in...
Neglected diseases such as leishmaniasis, trypanosomiasis, Chagas disease and malaria have a...